NO FEE UNLESS WE WIN
FREE CASE REVIEW

Good News for EpiPen® Auto-Injector Users and Families!

Mylan today issued a statement announcing that it is taking immediate action to increase access to EpiPen® Auto-Injectors by expanding already existing programs in recognition of those patients who are facing the burden of higher out-of-pocket costs, reducing direct patient costs and increasing eligibility for patient assistance programs for uninsured and under-insured patients.